A subset of patients with cancer have pain that is refractory to multimodal noninterventional therapies. 11, 13 In this group of patients, interventional therapies such as neuroablation or intrathecal drug delivery can be considered. Neuroablation in the form of percutaneous cordotomy or myelotomy can be an effective intervention for cancer pain. 9 However, patients with widespread pain and those with a significant psychological component to their pain may not be appropriate candidates for these interventions. Several reports have described the effectiveness of cingulotomy in treating refractory cancer pain. However, the role of this procedure in today's framework for the management of cancer pain is not well understood. The goal of this review was to review the existing literature and provide a framework for further studies of cingulotomy for cancer pain.
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Anatomical Basis
The cingulate gyrus is located on the medial part of the cerebral hemispheres and travels around the corpus callosum, separated from it by the pericallosal sulcus. Studies have demonstrated that the cingulate gyrus serves a role in the processing of cognitive, motor, emotional, pain, and visuospatial functions. 20 The cingulate gyrus can be broadly divided into the ACC and the PCC, which have differing patterns of projection and cytoarchitecture. 4 The ACC, which is thought to play a dominant role in cognitive and emotional processing, is also involved with the descending modulation of pain. 19 Neuroimaging studies with functional MRI, PET, and SPECT have supported the view that the ACC helps in modulation of nociceptive information in somatosensory areas. 6, 15 Although the exact pathophysiological role of the ACC in pain perception is not completely understood, it is accepted that the ACC and its connections with the prefrontal cortex play an important role in emotional response to pain. Particularly, the ACC helps determine how pain is perceived rather than how it is sensed. 17 Brodmann areas 24a, 24b, and 25 in the ventral ACC also have connections to the amygdala, striatum, and thalamic nuclei, suggesting its roles in the processing of emotions, behavior, and motivational states.
These findings have supported the physiological basis for lesioning the cingulate gyrus in the treatment of both psychiatric and pain disorders. Early studies of cingulotomy for psychiatric illness found that certain patients would have relief of intractable pain conditions and alleviation of withdrawal symptoms from opioid use. 3 This furthered the concept of cingulotomy in the treatment of intractable pain, and particularly pain conditions with a significant emotional component.
Methods
A search of PubMed, PubMed Central, the Cochrane Library, and MEDLINE was performed to identify all articles discussing cingulotomy for cancer pain. The text strings "cingul*" and "pain" were separated by the Boolean AND operator, and used to perform the query on PubMed (command/ cingul*[title] AND pain[title]). Only studies using a stereotactic technique, as opposed to an open one, and specifically detailing outcomes for cancer pain were included. For centers with multiple publications, care was taken not to double-count individual patients.
Results
Identification of Relevant Studies
The initial literature search yielded 124 results. A careful review of the titles, abstracts, and (where needed) the manuscript helped us to determine that 112 articles were not relevant to this review, because they did not focus on stereotactic cingulotomy, or they focused on noncancer pain. An additional 4 studies either did not include adequate outcomes assessment 2 or contained patients whose cases were republished at a later date. 10 This left 8 studies that fit our inclusion criteria (Table 1) .
Operative Techniques
A number of techniques for stereotactic cingulotomy have been reported in the literature. Early reports of cingulotomy used air ventriculograms to delineate the cerebral anatomy. Bur holes were placed 1.3 cm from the midline and 9 cm posterior to the nasion. A specially designed ventricular needle, which could also be used to perform the thermocoagulation, was then inserted into the frontal horn of the lateral ventricles. After needle insertion, 5-15 cm 3 of air was injected, and radiographic studies were performed to delineate the ventricular anatomy. Lesions were made variably between 1 cm and 4 cm posterior to the anterior tip of the frontal horn, approximately 5 mm from the midline. 2, 8 With increasing imaging capabilities and the advent of a stereotactic frame, cingulotomy could be performed more precisely with the aid of MRI guidance. 10 In the technique published by Hassenbusch et al., 10 the BrownRoberts-Wells stereotactic frame was secured to the patient after local anesthesia was induced, and a 1.5-T MRI study was performed with the head frame in place. The target for the cingulotomy was selected as 24 mm posterior to the anterior extent of the frontal horn, and the center of the cingulate gyrus was identified at this level. A radiofrequency electrode with a 10-mm exposed tip was then advanced so that the center of the exposed tip was at the target. A single lesion was made bilaterally at 75°C for 60 seconds each.
The senior author (T.Z.A.) has used a CT-MRI fusion technique (Fig. 1) . On the day of the procedure, the patient is given 10 mg of intravenous dexamethasone, and the Cosman-Roberts-Wells frame is applied. A stereotactic CT scan is then performed and fused to a preoperatively obtained MRI study. The target is selected as 20 mm posterior to the tip of the frontal horn of the lateral ventricle, 10 mm from midline, and 1-2 mm above the roof of the lateral ventricle. Two radiofrequency lesions are performed on each side at 80°C for 90 seconds each by using a radiofrequency electrode with a 10-mm exposed tip. After the first lesion, the radiofrequency electrode is withdrawn by 10 mm to perform the second lesion. A third lesion can be considered targeting the more lateral cingulum. The procedure is performed under local anesthesia, and via a twist drill hole placed 1.5 cm from midline at the level of the coronal suture.
Postoperative Outcomes
One of the earliest studies of cingulotomy for pain was Foltz and White's report on the treatment of 6 patients with cancer-related pain in 1962. 8 The patients had strong emotional factors associated with their pain including anxiety and depression, which augmented their symptoms. Pain locations included the face and neck (3 patients), back and hip (2 patients), and shoulder and arm (1 patient). Of this group, 2 patients had excellent results, 3 had good results, and in 1 the results were fair. Two patients underwent a unilateral cingulotomy and the other patients underwent bilateral cingulotomies. Postoperatively, patients did not experience significant withdrawal symptoms despite abrupt cessation of opioids.
In 1971, Faillace et al. described the outcomes in 7 patients with cancer pain who underwent cingulotomy. 7 All the patients with cancer pain had significant emotional factors that contributed to their pain. The target was 3.5-4 cm posterior to the tip of the frontal horn, which was reached using a surgical technique similar to that of Foltz and White. Three of the 7 patients had improvement in their pain that lasted for 3 days to 3 months. The other 4 patients did not experience improvement. The authors also reported the cognitive outcomes of their patients and found a significant decrease in performance on a nonverbal ordering test. Overall, however, the cognitive outcomes did not show significant changes from baseline.
The largest series of cingulotomy for cancer pain was published by Hurt and Ballantine in 1974. 12 The authors treated 32 patients with advanced cancer who had a range of cancers including lung, gastrointestinal, head, neck, melanoma, and sarcoma. In their series, 32% of patients had either complete or marked pain relief, 19% had moderate pain relief, and 44% had slight or no relief. There were no deaths in their series. Transient headache and fever were noted, and less commonly bladder or bowel incontinence and confusion were noted. These symptoms did not persistent beyond the 2nd postoperative week. Voris and Whisler 21 reported their experience with stereo-tactic intracranial lesioning in 90 patients in 1975. In their series, 5 patients underwent bilateral cingulotomy for the treatment of cancer pain. These investigators followed a technique similar to that of Foltz and White, and separate coagulations were made 13 mm and 17 mm posterior to the tip of the anterior horn. Over a follow-up period of 1-12 months, the authors reported that these 5 patients had pain relief until death. Using modern MRI-guided stereotactic techniques, Pillay and Hassenbusch 16 reported their results in 9 patients with cancer-related pain who underwent cingulotomy. The median preoperative numerical pain score was 9, and the median postoperative numerical pain score was 4. One patient developed postoperative global aphasia, which resolved by 10 days after surgery. Postoperatively each patient's analgesic dose requirement markedly decreased. In addition, the authors reported improved cognition, especially concentration and perception, and there were no changes in or flattening of affect. In 1997, an additional 3 patients were reported from the MD Anderson Cancer Center, 2 of whom had excellent pain outcomes. 23 The third patient's postoperative course was complicated by a flattened affect and paranoid ideations. She also did not have significant benefit with regard to pain.
Most recently, Yen et al. 25 detailed their experience treating 15 patients who had refractory cancer pain with bilateral anterior cingulotomy between August 2001 and December 2002. The target chosen was 24 mm posterior to the anterior tip of the frontal horn of the lateral ventricle. Bur holes were placed 2 cm lateral to the midline, and 1 or 2 lesions were made 3 mm apart bilaterally by using a 2-mm exposed tip radiofrequency electrode at 80°C for 80 seconds. In the week following surgery, 8 patients (53%) reported significant pain relief, 4 patients (27%) reported meaningful relief, and 3 patients (20%) reported little improvement. Sixty-six percent of patients with cancer pain showed definite pain relief at the 1-month follow-up, which decreased to 50% at 6 months. An additional series of 10 patients with cancer pain, who were treated between September 2002 and April 2004, was reported by the authors in 2009. 24 In this group, 40% of patients had greater than 75% pain relief, and an additional 2 patients had between 25% and 75% pain relief. This result was seen at both 1 week postoperatively and at the 3-month follow-up.
In their report from 2009, Yen et al. 24 also reported the impact of bilateral cingulotomy on cognition in 10 patients with intractable pain. Neuropsychological assessments were performed 1 day before surgery and at 1 week and 1 month postoperatively. There were no notable effects on cognitive functions including language, memory, intellect, and motor and visual-constructional skills. There was, however, a decline in focused attention performance in the early postoperative period as determined by the Stroop interference test. Two patients with good pain relief developed transient and self-resolving inappropriate and uninhibited speech for 2 days.
Adverse events reported include rare transient postoperative spasticity and hemiparesis, bleeding, transient postoperative confusion, ataxia, mild weight gain, transient bowel and bladder incontinence, seizures, increased appetite, decreased memory, and in a very few cases, cardiovascular complications. Headache, nausea, fever, and urinary incontinence may last for up to 48 hours. No deaths or infections were reported in a review of 800 cingulotomies performed at the Massachusetts General Hospital, although 1% of the patients had a seizure postoperatively. 1, 5 Frontal syndromes including apathy and decreased activity and spontaneity have been more frequently reported. 22 Significant neurocognitive defects are rare, but have been reported. 18 
Discussion
Despite increasing multidisciplinary efforts to treat cancer pain, there is a subset of patients who suffer. Using CT guidance has made neuroablative techniques such as cordotomy and myelotomy safer and more effective. These interventions can be considered early in the pain management algorithm for patients with unilateral nociceptive pain (cordotomy) or visceral midline pain (myelotomy). The use of neuromodulation in the form of intrathecal drug delivery is another option for the management of cancer pain, especially in patients with multiple pain sites. Opioids (either alone or in combination with local anesthetic agents) or the use of ziconotide can be effective, especially in patients who have side effects associated with the systemic administration of opioids.
In advanced cancer, however, it is not uncommon to see patients with diffuse pain syndromes, head and neck malignancies, and significant emotional distress associated with their pain. These are patients who will most likely not benefit from cordotomy, myelotomy, or intrathecal opioids. In these patients approaches such as cingulotomy could be considered.
Conclusions
The present literature supports the conclusion that bilateral stereotactic cingulotomy can be performed safely with minimal noticeable cognitive changes. Further controlled studies are warranted to determine the role of cingulotomy in the management of refractory cancer pain.
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